Balanced news tone
News Sentiment
CHOSA sentiment intelligence
CHOSA Oncology AB news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
13 relevant articles
News tone and price action are not far from neutral.
92/100 classification confidence.
directly relevant articles
high-authority source matches
-3.9% over one week, -9.6% over four weeks, trend inactive, and near fair-value range.
Chosa Oncology receives SEK 2.8m from warrants
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
92/100 classification
One-week reaction
-3.9%
Price reacting lower
Trend fit
Trend inactive
-9.6% over four weeks
Fair value
-7.0%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
1
Neutral
12
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
marketscreener.com
Direct company coverage
Chosa Oncology receives SEK 2.8m from warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 13:01
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
Chosa recruits Bill Cronin for US expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 10 Jul 2026 06:36
- Source
- marketscreener.com
marketscreener.com
Direct company coverage
CHOSA: CHOSA Oncology appoints US commercialization Bill Cronin with a broad network in the oncology market, to accelerate launch of Platin-DRP
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 06:36
- Source
- marketscreener.com
medwatch.com
Direct company coverage
Denmark's Chosa Oncology moves to Boston to adapt cancer test for US market — and make it marketable
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- medwatch.com
marketscreener.com
Direct company coverage
Chosa Oncology Begins Subscription Period for Warrants
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- marketscreener.com
TradingView
Direct company coverage
Bulletin from the annual general meeting on 13 June 2025 in Chosa Oncology AB
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jun 2025 07:00
- Source
- TradingView
Biostock
Direct company coverage
BioStock Investor Pitch: Chosa Oncology
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2025 07:00
- Source
- Biostock
Biostock
Direct company coverage
Chosa develops next generation chemotherapy
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 May 2025 03:06
- Source
- Biostock
Mingtiandi
Direct company coverage
GLP Japan Boss Chosa to Speak at Mingtiandi Tokyo Forum
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Oct 2024 07:00
- Source
- Mingtiandi
TradingView
Direct company coverage
CHOSA Stock Price and Chart — NGM:CHOSA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2023 16:12
- Source
- TradingView
Biostock
Direct company coverage
Chosa Oncology's CEO about the company and its development
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jan 2023 08:00
- Source
- Biostock
Biostock
Direct company coverage
RhoVac becomes Chosa Oncology after acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 20 Jan 2023 09:55
- Source
- Biostock
Biostock
Direct company coverage
Chosa Oncology gets Chinese patent green light
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Dec 2022 08:00
- Source
- Biostock